Medicine and Dentistry
Free Tissue Graft
100%
Head and Neck Cancer
64%
Wart Virus
60%
Systematic Review
56%
Oropharynx Squamous Cell Carcinoma
52%
Overall Survival
46%
Neck
44%
Oropharynx Carcinoma
41%
Head and Neck Squamous Cell Carcinoma
38%
Malignant Neoplasm
36%
Radiation Therapy
33%
Surgery
32%
Disease
30%
Recurrent Disease
30%
Hazard Ratio
29%
Oral Cavity
28%
Neoplasm
27%
Meta-Analysis
26%
Squamous Cell Carcinoma
26%
Oral Cancer
21%
Neck Dissection
20%
Adjuvant Therapy
20%
Fibula
19%
Skull Base
19%
Microvascular Reconstruction
17%
Cancer
15%
Odds Ratio
14%
Chemoradiotherapy
14%
Cisplatin
12%
Surgical Margin
12%
Lymph Node
11%
Base
11%
Head Reconstruction
11%
Neck Reconstruction
11%
Surgical Infection
11%
Fistula
11%
Robot-Assisted Surgery
10%
Induction Chemotherapy
10%
Comorbidity
10%
Postoperative Complication
10%
Retrospective Cohort Study
10%
Quality of Life
9%
Parotidectomy
9%
Graft Failure
9%
Donor Site
9%
Bone Necrosis
9%
Tongue
9%
Gastrostomy
9%
T Cell
9%
Smoking
9%
Keyphrases
Head-and-neck Cancer
77%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
68%
High-risk Human Papillomavirus (HR-HPV)
46%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
45%
Head-and-neck
44%
Free Flap Reconstruction
43%
Overall Survival
35%
Free Flap
32%
Confidence Interval
29%
Flap
27%
Transoral Surgery
26%
Meta-analysis
26%
Neck Dissection
22%
Radiation Therapy
22%
Locally Advanced
20%
Adjuvant Therapy
20%
Risk Factors
20%
Hazard Ratio
19%
Tumor
19%
Systematic Meta-analysis
19%
Oral Cavity Cancer
17%
Fibula Free Flap
17%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
16%
Microvascular Reconstruction
16%
Cisplatin
16%
Nasopharyngeal Carcinoma
16%
Functional Outcome
15%
Skull Base
15%
Resection
15%
Multi-institutional
14%
Surgery Therapy
13%
Free Tissue Transfer
13%
Phase II Trial
13%
National Cancer Database
13%
Positive Margins
12%
Prognostic Significance
12%
Flap Outcomes
12%
Flap Reconstruction
12%
Head Neck Reconstruction
12%
Human Papillomavirus Negative
11%
Non-associated
11%
Extranodal Extension
11%
Multivariable
11%
Radial Forearm Free Flap
11%
Induction Chemotherapy
11%
Locoregional Recurrence
11%
Odds Ratio
11%
Transoral Robotic Surgery
10%
Neoadjuvant
10%
Laryngoscope
10%